Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
Gynecologic cancers; Lymphedema; Oncologic surgical treatment; Patient reported outcomes; Quantitative measurements
© 2020 Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.
Russo, S., Walker, J., Carlson, J., Carter, J., Ward, L., Covens, A., Tanner, E., Armer, J., Ridner, S., Hayes, S., Taghian, A., Brunelle, C., Lopez-Acevedo, M., Davidson, B., Schaverien, M., Ghamande, S., Bernas, M., Cheville, A., Yost, K., Schmitz, K., Coyle, B., Zucker, J., Enserro, D., Pugh, S., Paskett, E., Ford, L., & McCaskill-Stevens, W. (2021). Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecologic Oncology, 160 (2). http://dx.doi.org/10.1016/j.ygyno.2020.10.026